Samcheondang Pharmaceutical drew investor attention as a dynamic volatility control mechanism (VI) was triggered amid heightened volatility early in the trading session.

As of the morning of the 9th, Samcheondang Pharmaceutical is trading at 190,500 won, up 0.69% from the previous trading day. Buy orders flooded in right after the market open, causing the stock price to move rapidly. Trading resumed normally after the volatility control mechanism was activated shortly thereafter.

According to the exchange, a dynamic VI was triggered in the NXT market at 8:00:06 a.m., with the trigger price set at 188,700 won. The dynamic VI reference price at the time was calculated at 172,300 won, and the deviation rate from the reference was 9.51%. The VI was subsequently lifted at 8:02:06 a.m., and normal trading resumed.

The Volatility Control Mechanism (VI) is a system that implements single-price trading for a certain period when a stock's price fluctuates sharply within a short timeframe. It is designed to mitigate investment risks associated with sudden price movements and to provide market participants with time to revise their orders or make investment decisions.

Samcheondang Pharmaceutical is a biotech company expanding its business centered on the development of ophthalmic treatments and biopharmaceuticals. The increased stock price volatility is interpreted as a result of intraday buying interest amid recently improving investor sentiment toward the broader biotech sector.

The market evaluates the VI trigger as an institutional mechanism signaling a temporary widening of price fluctuations, rather than a predictor of a specific stock's upward or downward trend. Future stock price movements are expected to be influenced by key variables such as R&D achievements, earnings performance, investor sentiment in the biotech sector, and supply and demand from institutional and foreign investors.

[This article was written with the assistance of AI, and its content is based on publicly available data and market information. Some information may change over time, so investors are advised to verify official materials, including Korea Exchange disclosures and corporate filings, before making investment decisions. This article is not intended to recommend the purchase or sale of any specific stock or to solicit investment, and the final judgment and responsibility for investments lie with the reader.]